In vivo synaptic transmission in young and aged amyloid precursor protein transgenic mice

Brain Research

Volumn 876, Issue 1-2, 2000, Pages 185-190

  Giacchino, Jeannie ^a   Criado, José R ^a   Games, Dora ^b   Henriksen, Steven ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b ELAN PHARMACEUTICALS   (United States)

Author keywords

Alzheimer's Disease; Amyloid precursor protein; Dentate gyrus; Hippocampus; Long term potentiation; Paired pulse facilitation

Indexed keywords

AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; ARTICLE; DISEASE ASSOCIATION; HIPPOCAMPUS; MOUSE; NERVE CELL PLASTICITY; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION; TRANSGENIC MOUSE;

ACTION POTENTIALS; AGING; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ELECTROPHYSIOLOGY; FEMALE; HIPPOCAMPUS; MICE; MICE, TRANSGENIC; MUTATION; NERVE DEGENERATION; NEURAL PATHWAYS; NEURONAL PLASTICITY; PRESYNAPTIC TERMINALS; REFERENCE VALUES; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 0034623106     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02615-9     Document Type: Article

References (31)

1. Andra K., Abramowski D., Duke M., Probst A., Wiederhold K.H., Burki K., Goedert M., Sommer B., Staufenbiel M. Expression of APP in transgenic mice: a comparison of neuron-specific promoters. Neurobiol. Aging. 17:1996;183-190.
2. Bahr B.A., Hoffman K.B., Yang A.J., Hess U.S., Glabe C.G., Lynch G. Amyloid beta protein is internalized selectively by hippocampal field CA1 and causes neurons to accumulate amyloidogenic carboxyterminal fragments of the amyloid precursor protein. J. Comp. Neurol. 397:1998;139-147.
3. Bobinski M., de Leon M.J., Tarnawski M., Wegiel J., Reisberg B., Miller D.C., Wisniewski H.M. Neuronal and volume loss in CA1 of the hippocampal formation uniquely predicts duration and severity of Alzheimer disease. Brain Res. 805:1998;267-269.
4. Braak E., Braak H. Alzheimer's disease: transiently developing dendritic changes in pyramidal cells of sector CA1 of the Ammon's horn. Acta Neuropathol. (Berl.). 93:1997;323-325.
5. Chapman P.F., White G.L., Jones M.W., Cooper-Blacketer D., Marshall V.J., Irizarry M., Younkin L., Good M.A., Bliss T.V., Hyman B.T., Younkin S.G., Hsiao K.K. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci. 2:1999;271-276.
6. Chartier-Harlin M.C., Crawford F., Houlden H., Warren A., Hughes D., Fidani L., Goate A., Rossor M., Roques P., Hardy J., et al. Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature. 353:1991;844-846.
7. Chen K.S., Masliah E., Grajeda H., Guido T., Huang J., Khan K., Motter R., Soriano F., Games D. Neurodegenerative Alzheimer-like pathology in PDAPP 717V - >F transgenic mice. Prog. Brain Res. 117:1998;327-334.
8. Clark R.F., Goate A.M. Molecular genetics of Alzheimer's disease. Arch. Neurol. 50:1993;1164-1172.
9. Dobrunz L.E., Huang E.P., Stevens C.F. Very short-term plasticity in hippocampal synapses. Proc. Natl. Acad. Sci. USA. 94:1997;14843-14847.
10. Dodart J.C., Meziane H., Mathis C., Bales K.R., Paul S.M., Ungerer A. Behavioral disturbances in transgenic mice overexpressing the V717F beta-amyloid precursor protein. Behav. Neurosci. 113:1999;982-990.
11. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates. 1997;Academic Press, San Diego.
12. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717b-amyloid precursor protein. Nature. 373:1995;523-527.
13. Giese K.P., Fedorov N.B., Filipkowski R.K., Silva A.J. Autophosphorylation at Thr286 of the alpha calcium-calmodulin kinase II in LTP and learning. Science. 279:1998;870-873.
14. Honer W.G., Dickson D.W., Gleeson J., Davies P. Regional synaptic pathology in Alzheimer's disease. Neurobiol. Aging. 13:1992;375-382.
15. Hsia A.Y., Masliah E., McConlogue L., Yu G.Q., Tatsuno G., Hu K., Kholodenko D., Malenka R.C., Nicoll R.A., Mucke L. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. USA. 96:1999;3228-3233.
16. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., et al. Correlative memory deficits, Ab elevation and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
17. Hyman B.T., Van Hoesen G.W., Kromer L.J., Damasio A.R. Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann. Neurol. 20:1986;472-481.
18. Ikezu T., Okamoto T., Komatsuzaki K., Matsui T., Martyn J.A., Nishimoto I. Negative transactivation of cAMP response element by familial Alzheimer's mutants of APP. EMBO J. 15:1996;2468-2475.
19. Irizarry M.C., Soriano F., McNamara M., Page K.J., Schenk D., Games D., Hyman B.T. Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J. Neurosci. 17:1997;7053-7059.
20. Jones M.W., Bliss T.V.P., Hsiao K.K., Chapman P.F. Age-dependent deficits in spatial memory and hippocampal LTP in vivo in APP transgenic mice. Soc. Neurosci. Abstr. 24:1998;729.
21. Justice A., Motter R. Behavioral characterization of PDAPP transgenic Alzheimer mice. Soc. Neurosci. Abstr. 23:1997;1637.
22. Lambert M.P., Barlow A.K., Chromy B.A., Edwards C., Freed R., Liosatos M., Morgan T.E., Rozovsky I., Trommer B., Viola K.L., Wals P., Zhang C., Finch C.E., Krafft G.A., Klein W.L. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA. 95:1998;6448-6453.
23. Larson J., Lynch G., Games D., Seubert P. Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice. Brain Res. 840:1999;23-35.
24. Lee S.J., Liyanage U., Bickel P.E., Xia W., Lansbury P.T. Jr., Kosik K.S. A detergent-insoluble membrane compartment contains A beta in vivo. Nat. Med. 4:1998;730-734.
25. Manabe T., Wyllie D.J., Perkel D.J., Nicoll R.A. Modulation of synaptic transmission and long-term potentiation: effects on paired pulse facilitation and EPSC variance in the CA1 region of the hippocampus. J. Neurophysiol. 70:1993;1451-1459.
26. Masliah E., Sisk A., Mallory M., Mucke L., Schenk D., Games D. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease. J. Neurosci. 16:1996;5795-5811.
27. Moechars D., Dewachter I., Lorent K., Reverse D., Baekelandt V., Naidu A., Tesseur I., Spittaels K., Haute C.V., Checler F., Godaux E., Cordell B., Van Leuven F. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J. Biol. Chem. 274:1999;6483-6492.
28. Moechars D., Lorent K., De Strooper B., Dewachter I., Van Leuven F. Expression in brain of amyloid precursor protein mutated in the alpha- secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice. EMBO J. 15:1996;1265-1274.
29. Murrell J., Farlow M., Ghetti B., Benson M.D. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science. 254:1991;97-99.
30. Sturchler-Pierrat C., Abramowski D., Duke M., Wiederhold K.H., Mistl C., Rothacher S., Ledermann B., Burki K., Frey P., Paganetti P.A., Waridel C., Calhoun M.E., Jucker M., Probst A., Staufenbiel M., Sommer B. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. USA. 94:1997;13287-13292.
31. Winder D.G., Mansuy I.M., Osman M., Moallem T.M., Kandel E.R. Genetic and pharmacological evidence for a novel, intermediate phase of long-term potentiation suppressed by calcineurin. Cell. 92:1998;25-37.